Congress·In Committee·S. 3788

Senate CLEAR LABELS Act Would Require Drug Labels to Show Where Medicines Are Made

CLEAR LABELS Act

about 2 months ago·View on Congress.gov

Legislative Progress

Senate

House

President

Law

Key Points

Congress is considering a new law that would require medicine labels to clearly show exactly where your drugs are made. Currently, it can be difficult for consumers to tell which company or country actually manufactured the specific ingredients in their prescriptions.
Drug companies would have to list the name and location of the original factory that made the medicine's active ingredients, as well as the factory that finished the final product. This information could be printed directly on the packaging or accessed through a QR code or a website link.
This change aims to give patients and doctors more transparency about the global supply chain for medicine. If there is a safety issue or a recall at a specific factory overseas, people would be able to check their own medicine bottles to see if their pills came from that location.
The rules would apply to both the raw ingredients used to make drugs and the final pills or liquids sold to consumers. Companies would also be required to provide a paper copy of this manufacturing information to any individual who asks for it.
If passed, the government would create specific rules for how these labels should look. These new requirements would start at least one year after the final rules are finished, giving drug companies time to update their packaging and systems.

Healthcare

Impact Analysis

Personal Impact

Who is affectedScoreImpactCertaintyScopeDurationSentiment

Scores: 1 = low, 5 = highSentiment: -5 to +5 (net benefit)

Milestones

2 milestones3 actions

Mar 19, 2026Senate

Committee on Health, Education, Labor, and Pensions. Hearings held.

Feb 5, 2026Senate

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Feb 5, 2026

Introduced in Senate

Related News

3 articles

Florida Politics·about 2 months ago

Delegation for 1.30.26: labels

Senator Rick Scott introduced the CLEAR LABELS Act to mandate country-of-origin labeling for prescription drugs. The bill addresses concerns about the quality of generic drugs imported from China and India, noting that only 37% of pharmaceuticals consumed in 2024 were manufactured in the U.S.

Ommcom News·about 1 month ago

US Senators Seek Drug Origin Labels

Senators Kirsten Gillibrand and Rick Scott introduced the CLEAR LABELS Act to require drug labels to disclose where medicines and their key ingredients are made. The move aims to increase transparency in a supply chain heavily reliant on overseas manufacturing in countries like China and India.

The Hill·almost 2 years ago

Rubio, Smith introduce bill to require country of origin labeling for drugs

In an earlier iteration of the policy, Senators Marco Rubio and Tina Smith introduced legislation to require drug labels to list the country of origin for active pharmaceutical ingredients. The bill seeks to reduce U.S. reliance on foreign drug manufacturing and improve supply chain oversight.